Name | Value |
---|---|
Revenues | 186.7M |
Cost of Revenue | 53.8M |
Gross Profit | 132.9M |
Operating Expense | 151.6M |
Operating I/L | -18.7M |
Other Income/Expense | 4.3M |
Interest Income | 5.3M |
Pretax | -14.4M |
Income Tax Expense | -0.2M |
Net Income/Loss | -14.2M |
iRhythm Technologies, Inc. is a digital healthcare company specializing in ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. Its flagship Zio service offers a wire-free, patch-based, and wearable biosensor combined with a cloud-based data analytic platform, enabling physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors are single-use, wire-free, wearable patch-based biosensors that record patient's heartbeats and ECG data. iRhythm generates revenue by selling its monitoring products and services to healthcare providers and patients.